首页> 中文期刊> 《中国美容医学》 >自拟祛疣汤联合重组干扰素α-2b治疗多发性扁平疣疗效观察

自拟祛疣汤联合重组干扰素α-2b治疗多发性扁平疣疗效观察

         

摘要

Objective To observe the effect of Quyou decoction combined with recombinant human interferon alpha-2b local blocking curative effect in the treatment of lfat wart.Methods Random 128 patients with verruca plana patients were divided into two groups, treatment group (66 cases) was treated with self-made Quyou decoction combined with recombinant human interferon alpha-2b local closed treatment. The control group (62 cases) were treated with recombinant human interferon alpha-2b local closed treatment. Results In the treatment group, 54 cases were cured,3 cases were markedly effective, 8 cases ineffective, cure rate was 81.2%, effective rate was 86.4%; in the control group, 38 cases were cured,12 cases were markedly effective,12 cases were ineffective, cure rate was 61.3%, 80.6%. Two groups have efficiency differences had no statistical significance (χ2 =1.81%,P>0.05); treatment group healed rate was significantly higher than that of the control group, the difference is statistically signiifcant (P<0.01).Conclusion The cure rate is signiifcant by Quyou decoction combined with recombinant human interferon alpha 2b intramuscular injection to treat lfat wart. It is worthy of clinical application.%目的:观察自拟祛疣汤联合重组人干扰素α-2b肌注治疗扁平疣的疗效。方法:采用随机方法将128例扁平疣患者分组,治疗组:66例,采用自拟祛疣汤联合重组人干扰素α-2b肌注治疗;对照组:62例,采用重组人干扰素α-2b肌注治疗。结果:治疗组痊愈54例,显效3例,无效8例,痊愈率81.2%,有效率86.4%;对照组痊愈38例,显效12例,无效12例,痊愈率61.3%,有效率80.6%,两组有效率比较差异无统计学意义(χ2=1.81%,P>0.05);治疗组痊愈率明显高于对照组,差异有统计学意义(P<0.01)。结论:自拟祛疣汤联合重组人干扰素α-2b肌注中西医结合治疗扁平疣治愈率显著,值得临床推广应用。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号